Skip to main content
. 2012 Jul 10;53(5):791–797. doi: 10.1093/jrr/rrs033

Fig. 3.

Fig. 3.

Dosages that covered 90% of the HR CTV were compared between the Manchester plan (white columns) and the IBICBT plan (gray columns) for each patient. We could control the D90 (HR CTV) values of all patients to 100% PD. In contrast, median D90 (HR CTV) per fraction was 116.1% PD (90.0–150.8%) for the Manchester plan. Seven of the eight patients showed higher values in the Manchester plan than in the IBICBT plan. However, Patient 8, whose HR CTV was >61 ml, showed a lower value.